Insider Trading & Ownership of Gino Santini

Location
Waltham, MA
Summary
The estimated net worth of Gino Santini is at least $3,534,726 dollars as of 19 Aug 2025. Gino Santini is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $3.53M.
Signature
/s/ Colleen Tupper as Attorney-in-Fact for Gino Santini
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Gino Santini and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Gino Santini has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,534,726.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: COLLEGIUM PHARMACEUTICAL, INC ($3,534,726).
  • Past-year value change for that position: -$201,018.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gino Santini

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $3,534,726 -$201,018 -5.4% 15 Aug 2025
ALNAQ Allena Pharmaceuticals, Inc. Director 03 Jun 2021
CMPS COMPASS Pathways plc Director 12 Jun 2025
HZNP Horizon Therapeutics Public Ltd Co Director 06 Oct 2023
ICPT INTERCEPT PHARMACEUTICALS, INC. Director 08 Nov 2023

Insider Transactions Reported by Gino Santini:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .